Gilbert Syndrome and the Development of Antiretroviral Therapy–Associated Hyperbilirubinemia

Abstract

Genotyping for UGT1A1*28 before initiation of ART would identify HIV-infected individuals at risk for hyperbilirubinemia and decrease episodes of jaundice.